UNSPSC 51351611: Estropipate

This classification denotes a steroidal estrogen with the molecular formula C18H22O5S.C4H10N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier SVI38UY019, chemically known as 3-(sulfooxy)estra-1,3,5(10)-trien-17-one, w/pip* but generally known as estropipate, which bears US NIH Compound Identifier 23703. European Medicines Agency schedules Estropipate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13724MIG. As of Q4 2014, ESTROPIPATE remains the US FDA Preferred Term for this commodity.

Estropipate bears US NLM identifiers UMLS ID C0071108 and NCI Concept Code C47521. SMILES: S(=O)(=O)(Oc1cc2c(C3C(C4C(CC3)(C(=O)CC4)C)CC2)cc1)O.N1CCNCC1.

UNSPSC 51351611 Estropipate, a Commodity code, names a pharmaceutical product — an oral estrogen replacement therapy — that state and local government health agencies, corrections departments, and public health clinics procure for inmate and patient populations. The code covers the active pharmaceutical ingredient and finished dosage forms used in hormone replacement therapy and related therapeutic applications within the public healthcare and correctional systems.

The source provides no recent state and local contract opportunities tagged to this code. Without posted solicitations or awarded contracts on record, no issuing-body mix, geographic concentration, or representative recent opportunities can be characterized from available data.